Sirpa Leppä

University of Helsinki

Finland

Research Interests

Explore related searches

Professors in Finland Professors in Immunology Immunology professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Amjad Alkodsi

University of Helsinki

FINLAND

View details

Oscar Brück

FINLAND

View details

Judit Meszaros Joergensen

Aarhus University

DENMARK

View details

Suvi-Katri Leivonen

University of Helsinki

FINLAND

View details

Jeanette Doorduijn

Erasmus University Rotterdam

NETHERLANDS

View details

Laura Kohtamäki

University of Helsinki

FINLAND

View details

Harald Holte

Senior consultant, head of lymphoma section

University of Oslo

NORWAY

View details

Micaela Hernberg

Associate professor

University of Helsinki

FINLAND

View details

Heli Vajavaara

University of Helsinki

FINLAND

View details

Pekka Ellonen

University of Helsinki

FINLAND

View details

Maija Helena Lepistö

University of Helsinki

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sirpa Leppä

Research Interests

Explore related searches

Contact this professor

Articles (10)

Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients

Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients

Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment

The EHA Research Roadmap

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study

Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma

Collaborators (11)

Amjad Alkodsi

Oscar Brück

Judit Meszaros Joergensen

Suvi-Katri Leivonen

Jeanette Doorduijn

Laura Kohtamäki

Harald Holte

Micaela Hernberg

Heli Vajavaara

Pekka Ellonen

Maija Helena Lepistö

Make your next move.